Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases

MLA

Camila B. Schmidt, et al. “Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases.” Current Gene Therapy, vol. 14, Aug. 2014, pp. 218–35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f714be0893ed5bcc3bf345541ac3362&authtype=sso&custid=ns315887.

APA

Camila B. Schmidt, Thomas Simon, Evelyn L. Jara, Alexis M. Kalergis, Susan M. Bueno, Sebastián A. Riquelme, Ignacio Anegon, Claudia A. Riedel, Juan Pablo Mackern-Oberti, & Carolina Llanos. (2014). Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases. Current Gene Therapy, 14, 218–235.

Chicago

Camila B. Schmidt, Thomas Simon, Evelyn L. Jara, Alexis M. Kalergis, Susan M. Bueno, Sebastián A. Riquelme, Ignacio Anegon, Claudia A. Riedel, Juan Pablo Mackern-Oberti, and Carolina Llanos. 2014. “Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases.” Current Gene Therapy 14 (August): 218–35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f714be0893ed5bcc3bf345541ac3362&authtype=sso&custid=ns315887.